Zinc finger and interferon-stimulated genes play a vital role in TB-IRIS following HAART in AIDS.

AIM Co-infection in HIV-1 patients with Mycobacterium tuberculosis poses considerable risk of developing the immune reconstitution inflammatory syndrome (IRIS), especially upon the initiation of antiretroviral therapy (ART). Methodology & results: For transcriptomic analysis, peripheral blood mononuclear cells' whole gene expression was used from three patient groups: HIV+ (H), HIV-TB+ (HT), HIV-TB+ with IRIS (HTI). Pathway enrichment and functional analysis was performed before and after highly active ART. Genes in the interferon-stimulating and ZNF families maintained tight functional interaction and tilted the balance in favor of TB-IRIS. DISCUSSION & CONCLUSION The functional impairment of interaction between ZNF genes and interferon-stimulated genes, along with higher expression of S100A8/S100A9 genes possibly forms the genomic basis of TB-IRIS in a subset of HIV patients while on highly active ART.

[1]  G. Barton,et al.  How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use? , 2015, RNA.

[2]  Y. Aida,et al.  Genome-wide transcriptional profiling reveals that HIV-1 Vpr differentially regulates interferon-stimulated genes in human monocyte-derived dendritic cells. , 2015, Virus research.

[3]  R. Wilkinson,et al.  HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome , 2015, Seminars in Immunopathology.

[4]  J. Banchereau,et al.  HIV–tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling , 2015, Nature Communications.

[5]  H. Nishitsuji,et al.  ZNF10 inhibits HIV‐1 LTR activity through interaction with NF‐κB and Sp1 binding motifs , 2015, FEBS letters.

[6]  X. Deng,et al.  Promotion of expression of interferon-stimulated genes in U937 monocytic cells by HIV RNAs, measured using stable isotope labeling with amino acids in cell culture (SILAC) , 2015, Archives of Virology.

[7]  Yu-huang Zheng,et al.  The immune pathogenesis of immune reconstitution inflammatory syndrome associated with highly active antiretroviral therapy in AIDS. , 2014, AIDS research and human retroviruses.

[8]  J. Casanova,et al.  Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation , 2014, Nature.

[9]  A. Sher,et al.  Mycobacterial Antigen Driven Activation of CD14++CD16− Monocytes Is a Predictor of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome , 2014, PLoS pathogens.

[10]  Y. Aida,et al.  HIV-1 Vpr Induces Interferon-Stimulated Genes in Human Monocyte-Derived Macrophages , 2014, PloS one.

[11]  Sharmistha Banerjee,et al.  Mycobacterial and HIV Infections Up-Regulated Human Zinc Finger Protein 134, a Novel Positive Regulator of HIV-1 LTR Activity and Viral Propagation , 2014, PloS one.

[12]  Peilin Jia,et al.  Transcriptome Sequencing and Genome-wide Association Analyses Reveal Lysosomal Function and Actin Cytoskeleton Remodeling in Schizophrenia and Bipolar Disorder , 2014, Molecular Psychiatry.

[13]  R. Wilkinson,et al.  Neutrophil-Associated Central Nervous System Inflammation in Tuberculous Meningitis Immune Reconstitution Inflammatory Syndrome , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Zolla-Pazner,et al.  Transcriptional Profiling of Mycobacterium tuberculosis Replicating Ex vivo in Blood from HIV- and HIV+ Subjects , 2014, PLoS ONE.

[15]  Kaushal S. Gandhi,et al.  Genome-wide analysis of primary peripheral blood mononuclear cells from HIV + patients-pre-and post- HAART show immune activation and inflammation the main drivers of host gene expression , 2014, Molecular and Cellular Therapies.

[16]  Jian‐qing Xu,et al.  [HIV-1 infection up-regulating expression of interferon-stimulated gene 15 in cell lines]. , 2013, Bing du xue bao = Chinese journal of virology.

[17]  F. Mascart,et al.  Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome , 2013, AIDS.

[18]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[19]  Jian Ye,et al.  Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction , 2012, BMC Bioinformatics.

[20]  C. Rice,et al.  Multiple Interferon Stimulated Genes Synergize with the Zinc Finger Antiviral Protein to Mediate Anti-Alphavirus Activity , 2012, PloS one.

[21]  D. Scott‐Algara,et al.  Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis. , 2012, Blood.

[22]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[23]  L. Montaner,et al.  Natural Killer Cell Activation Distinguishes Mycobacterium tuberculosis–Mediated Immune Reconstitution Syndrome From Chronic HIV and HIV/MTB Coinfection , 2011, Journal of acquired immune deficiency syndromes.

[24]  K. Yudoh,et al.  Increased expression of S100 calcium binding protein A8 in GM-CSF-stimulated neutrophils leads to the increased expressions of IL-8 and IL-16. , 2011, Clinical and Experimental Rheumatology.

[25]  Yong-tang Zheng,et al.  Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation , 2011, Proceedings of the National Academy of Sciences.

[26]  L. Haddow,et al.  Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome , 2011, AIDS.

[27]  Lokesh P. Tripathi,et al.  TargetMine, an Integrated Data Warehouse for Candidate Gene Prioritisation and Target Discovery , 2011, PloS one.

[28]  L. Rong,et al.  The IFITM Proteins Inhibit HIV-1 Infection , 2010, Journal of Virology.

[29]  D. Villines,et al.  Effect of human immunodeficiency virus infection on S100A8/A9 inhibition of peripheral neutrophils oxidative metabolism. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  V. Pascual,et al.  Assessing the human immune system through blood transcriptomics , 2010, BMC Biology.

[31]  E. Vicaut,et al.  Tuberculosis-Associated Immune Restoration Syndrome in HIV-1-Infected Patients Involves Tuberculin-Specific CD4 Th1 Cells and KIR-Negative γδ T Cells1 , 2009, The Journal of Immunology.

[32]  Rohan Williams,et al.  Gene expression in HIV-1/Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis. , 2009, Tuberculosis.

[33]  Christopher J. Nelson,et al.  Advantages of next-generation sequencing versus the microarray in epigenetic research. , 2009, Briefings in functional genomics & proteomics.

[34]  C. Geczy,et al.  IL-10-Dependent S100A8 Gene Induction in Monocytes/Macrophages by Double-Stranded RNA1 , 2009, The Journal of Immunology.

[35]  G. Maartens,et al.  Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. , 2008, American journal of respiratory and critical care medicine.

[36]  M. Fujita,et al.  Suppression of inflammation in rat autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine network , 2008, European journal of heart failure.

[37]  P. Reiss,et al.  Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. , 2008, The Lancet. Infectious diseases.

[38]  Ash A. Alizadeh,et al.  Cell-type specific gene expression profiles of leukocytes in human peripheral blood , 2006, BMC Genomics.

[39]  P. Pitha,et al.  Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15 , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Vicaut,et al.  Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients , 2006, AIDS.

[41]  P. Gibson,et al.  Evidence-based respiratory medicine / , 2005 .

[42]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  F. Rahimi,et al.  Regulation of S100A8 by Glucocorticoids1 , 2005, The Journal of Immunology.

[44]  P. Price,et al.  Immune restoration disease after antiretroviral therapy , 2004, AIDS.

[45]  James L. Buescher,et al.  Molecular Characterization of a Putative Antiretroviral Transcriptional Factor, OTK181 , 2004, The Journal of Immunology.

[46]  S. McColl,et al.  Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. , 2003, Arthritis and rheumatism.

[47]  W. Nacken,et al.  S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity , 2003, Microscopy research and technique.

[48]  Aaron Klug,et al.  Repression of the HIV-1 5′ LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  K. Sepkowitz,et al.  AIDS--the first 20 years. , 2001, The New England journal of medicine.

[50]  D. Pechkovsky,et al.  Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. , 2000, FEMS immunology and medical microbiology.

[51]  Carolyn L. Geczy,et al.  IFN-γ and TNF Regulate Macrophage Expression of the Chemotactic S100 Protein S100A81 , 2000, The Journal of Immunology.

[52]  P. Kissinger,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. , 1998, The New England journal of medicine.

[53]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[54]  C. Geczy,et al.  Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli. , 1997, Blood.

[55]  K. Xu,et al.  Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. , 1996, Blood.

[56]  Meng Chen,et al.  The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle , 1995, Journal of virology.

[57]  S. Frøland,et al.  Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events. , 1994, Journal of acquired immune deficiency syndromes.

[58]  S. Mallal,et al.  Zidovudine‐induced restoration of cell‐mediated immunity to mycobacteria in immunodeficient HIV‐infected patients , 1992, AIDS.

[59]  Masahide Horiba,et al.  OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions. , 2007, Journal of General Virology.

[60]  I. Stříž,et al.  Calprotectin - a pleiotropic molecule in acute and chronic inflammation. , 2004, Physiological research.

[61]  K. Xu,et al.  IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. , 2000, Journal of immunology.

[62]  Anthony D. Harries,et al.  Treatment of tuberculosis: guidelines for national programmes. Second edition. , 1997 .